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Abstract   In this study I have made efforts towards investigating healthcare in two arenas. First, 
can a model with life expectancy as a proxy for healthcare quality be used to objectify the study 
of efficiency in the G7 countries and Korea? Table 1 and the results section have illuminated 
many factor variables which vary between countries and characterize the environments in 
which different healthcare systems have developed. The analysis also illuminates an inherent 
structural difference in the mechanism of delivering healthcare throughout the developed 
world. Secondly, can these aggregate data be used to show us anything new about the studies 
performed by Peter Zweifel and Friedrich Breyer? Did the SISYPHUS Syndrome disappear in the 
early 1990s as Zweifel suggested in 2002? No, in Table 2 I have demonstrated through SURS 
that over the time period 1990-2009 there are clear statistically significant SISYPH variables in 
at least Canada, Germany, Korea, and Britain. Lastly, can I confirm Breyer’s model of HCE in 
Germany and can it be useful in other countries? Yes to extent possible the methodologies 
were replicated in a SURS fashion in an effort to simultaneously test and examine different 
variables in different countries. I was unable to confirm the results of Breyer in his 2011 
examination of the sickness fund members for Germany. However, I was able to offer primitive 
characterizations of the other G7 countries and Korea and how their HCE move.  
JEL Codes: I11∙ I12 ∙ I15 ∙ I18 
Key Words: healthcare expenditures ∙ healthcare factor variables ∙ sisyphus syndrome  
Introduction and Literature Review  
As technological advances lead to longer lives, it is critical to understand the mechanism of 
healthcare delivery. This increased livelihood results in more time spent retired and is bound to 
cause severe burdens on tax bases. In the United States for example, as the baby boom 
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generation has aged, an increasing financial burden is being placed on a shrinking taxable 
population to provide medical care. Although this conclusion is simple arithmetic it is not so 
clear if the increasing longevity of populations will necessarily increase health care 
expenditures. If government programs are going to survive there will have to be substantial 
structural and financial reforms broach this clear accounting divide.  
Policy debates in the US are currently taking place over whether to transform Medicare 
to a voucher based system or restructure a system of reimbursements to physicians. These 
decisions will require further empirical studies if we are to propose therapeutic reforms. 
Specifically how do the healthcare systems in the industrialized world react to the same factor 
variables, if at all? This study is developed in an effort to characterize general models for the 
determinants of life expectancy as a proxy variable for healthcare quality.  
 In economic circles, the nature of the correlation between healthcare expenditures, 
hereafter HCE, and an ageing population has been discussed actively for over a decade but is 
not well defined (Breyer 2011).  This relationship was theorized long ago to be positive (Fuchs 
1984) but in 1999, Zweifel et al. posit this to be erroneous. They show in studies of individual 
healthcare costs, after controlling for proximity to death, calendar age is not a significant 
regressor of HCE (Zweifel 1999). This result was confirmed multiple times, in 2004 and 2007 
(Stearns and Norton 2004, Seshamani and Gray 2004, Zweifel 2004, and Werblow 2007). This 
study will examine aggregate HCE as a percentage of GDP with respect to population 
distribution in an effort to shed some light on the relevant policy implications.     
 More recently, efforts have been made to appreciate specifically what effect life 
expectancy will have on HCE in a dynamic panel data context. Initially Zweifel et al. developed a 
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variable that showed statistical significance in predicting HCE (Zweifel 1999). This variable, 
termed SISYPH (for Sisyphus effect) was constructed as the product of life expectancy and 
percent of the population above 65. The economic theory behind the SISYPH variable is quite 
interesting; that health care delivery is similar to pushing a boulder up a hill until just before the 
edge it comes crashing back down upon you, just as in the myth of Sisyphus. In economic terms, 
Zweifel postulates an increase in HCE, for example a new government spending bill to have a 
positive effect on life expectancy, for a time more people will survive what used to be fatal. 
However, without structural reform this will simply increase demand on the same amount of 
supply until the current system is overtaxed and it’s not possible for more people to be treated 
even with more resources.  
This relationship is a prime example of diminishing marginal returns, potentially 
culminating in a state of negative returns where increased HCE actually reduce life expectancy. 
When SISYPH was regressed on HCE it was statistically significant, however, it is impossible to 
determine what significance is arising from the life expectancy component and what 
significance is arising from the ageing population component.  
Breyer et al. make an effort to detangle these correlations in their 2011 working paper. 
They use a 12 year dataset used to calculate risk adjustment payments between insurance 
funds including, age, life expectancy and HCE in Germany. They cite specific issues with 
previous studies related to the cross-sectional nature of the data and believe they should have 
more success in using their pseudo-panel. They report age, mortality rate, and life expectancy 
as all statistically significant positive regressors on HCE in a fixed-effects model.   
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This study will use a 17 year dataset including similar information in an effort to attempt 
to confirm the results published by both Zweifel and Breyer on an aggregated panel dataset for 
each of the G7 Countries and Korea in a SUR fashion.  
Data and Testable Hypotheses 
The data for this study were collected from two different sources. Data on HCE, pharmaceutical 
expenditures, # of physicians, # of hospital beds, vaccination rates against measles, vaccination 
rates against diphtheria, vaccination rates against influenza, life expectancy, remaining life 
expectancy at 65, tobacco consumption, and alcohol consumption were all obtained from the 
OECD iLibrary for the 8 countries in question. Data on incidence of tuberculosis, unemployment 
rates and percent population distribution, were all obtained from the World Bank Development 
Indicators Databank.  
Different variables tend to have data from differing start dates. The only consistently 
collected time period for all the variables was from approximately 1989-2009. Some variables 
were not reported for certain countries and year; any gaps were dealt with by combining World 
Bank and OECD data to form one coherent and continuous variable. As a result, 17 years in the 
above range, have observations for all variables and were regressed upon.  
Also certain variables had to be generated following literature sources. The SISYPH 
variable was generated for each of the 8 countries. It was constructed as the product of 
remaining life expectancy at 65 and percent of the population aged 65+.  
As the goals of this paper are essentially two fold there are two separate applications of 
SURS. First are the theoretical predictions for signs of variables in the life expectancy model: 
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 Year: As medical technology advances it follows with conventional wisdom that there 
would be a positive trend on life expectancy. 
 HCE: Intuitively increasing health expenditures should increase life expectancy. This is 
assuming that the additional resources are spent pseudo-efficiently.  
 Pharmaceutical Expenditures: A subset of the HCE is how resources are devoted to the 
pharmaceutical industry; this variable should capture some of the significance of 
increased production of advanced drugs and research and should be positive. 
 # Physicians per 1,000 Pop: The density of physicians with respect to population would 
intuitively be positive if this was the only factor allowing people who needed treatment 
to receive it.  
 # Hospital Beds per 1,000 Pop: The density of hospital beds with respect to population 
should also be positive. This variable has the potential to indicate the size of the 
demanded medical services industry. 
 Alcohol Consumption, Liters per Pop Aged 15+: Alcohol consumption in excess is clearly 
associated with a negative effect on life expectancy. However, depending on 
consumption habits this variable has the potential to be negative or positive. 
 Tobacco Consumption, % of Adults who Smoke Daily: Tobacco consumption is a terrible 
habit in medical terms. This variable should be a negative regressor on life expectancy. 
 Vaccination Rates against Diphtheria: Diphtheria is a bacterial infection which wreaks 
havoc on the upper respiratory tract with horrible consequences. Vaccination rates 
towards this disease should be positive. 
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 Vaccination Rates against Measles: The MMR vaccine provides protection from measles, 
mumps and rubella and would intuitively be a positive regressor on life expectancy.  
 Vaccination Rates against Influenza in Pop 65+: Influenza in elderly population has 
potentially life threatening consequences. This variable should be a positive regressor 
on life expectancy.  
 Incidence of Tuberculosis per 100,000 Pop: Tuberculosis is a disease which persists in the 
respiratory tract for prolonged periods causing bouts of pneumonia and eventually 
causing death if left untreated. It is extremely contagious and is especially prone in high 
population density areas. This variable should be a negative regressor.  
 Unemployment Rate: Unemployment rate was added to capture any impact on life 
expectancy resulting from the economic state. This regressor should be negative. 
The second model is that on HCE in an effort to predict the main driving forces on the ever 
ballooning costs in the healthcare industry. The theoretical predictions for this model follow: 
 Year: Coupled with increasing technology comes increased costs to develop and 
implement these new technologies. This regressor should be positive. 
 Log Life Expectancy: This is one of the main controversial regressors; theoretically a 
longer life presents more opportunities for health issues to arise. This should be a 
positive regressor but its magnitude is not clear. 
 Remaining Life Expectancy at 65: RLE captures people spending more of their life in an 
elderly state and should intuitively increase HCE; older people get sick more often.  
 Pop014: Very young populations generally require more care relative to middle aged, 
this should be a positive regressor but the magnitude is not clear. 
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 Pop1564: Middle aged populations generally require less care, this should be a negative 
regressor on HCE. 
 Pop65up: The percentage of people in their elderly years indicates a population which is 
generally not as healthy and should be a positive regressor on HCE.  
 SISYPH: The variable first constructed by Peter Zweifel in 1992 is composed of remaining 
life expectancy at 65 and the percentage of population 65+. This should be a positive 
regressor on HCE.  
Estimation Strategy 
The dataset for the 8 countries over 17 years is a dynamic panel. The SUR technique proposed 
by Arnold Zellner in 1962 is a method of simultaneously estimating a set of equations. Under 
the assumption that the error processes experience correlation, that is shocks effect each of 
the systems in a similar way, the technique can produce more efficient estimates than OLS. It 
also allows for simple tests of equality on parameters between. Its construction requires time 
periods, T to be greater than the number of equations, N.  
                                                                                                     
                                           
                                            
                                                                           
  
                                                                                                     
                                           
                                            
                                                                           
In my construction, T=17 and N=8. We tested the general models below and determined 
relative significance of the country specific factor variables on log life expectancy for each 
country CAN to USA. Here the dependent variable is log life expectancy for each country, the 
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single-log transformation was used to reduce the extrema in the data and more closely fit a 
linear estimation. 
The second set of models regressed were those of the form originally proposed and 
developed by Peter Zweifel; that which examines the SISYPHUS Syndrome. This study differs in 
that the models are estimated via SUR in an effort to examine differences between the 
countries. The construction of those models followed the form: 
                                    
  
                                    
 The third and final set of models regressed were related to the work by Friedrich Breyer 
and his efforts to detangle the effects of age composition of population and the remaining life 
expectancies, hereafter RLE, of the aged population. In our model we performed a similar 
estimation but for 8 countries with macro data as opposed to individuals with micro data. They 
were of the form: 
                                                                             
  
                                                                            
 
Regression Results and Discussion 
Examining Log LE Regressions: 
In Table 1 are the results for log LE as the dependent variable. Along the top row is each of the 
country specific models. In the first column are the country specific factor variables. 
Significance is denoted in two forms, first estimates are labeled with *, **, or *** to denote the 
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pval; also the actual pval lies below each estimate in parentheses. The models were refined by 
removing insignificant variables, at the .05 level, a – denotes insignificance in the model. 
All of the models have strong explanatory power, denoted by their R2, ranging from 
0.9952-0.9998 and pvals all equal to 0 to the fourth decimal place. All of the nations modeled 
are experiencing significant positive time trend on log LE. Within the time trend variable we see 
strikingly similar estimates for France, Germany, and Korea. A cross equation test of equality 
yields a pval=0.9260, it is not possible to reject the null of equality for the time trend. 
Roland Berger Consulting provides some descriptive statistics in their publication Trends in 
European Health Care of 2007, which would be of use in this analysis. Firstly, all three of these 
countries have a universal healthcare program of one form or another which have been, 
generally speaking quite successful. Germany has about 85% covered by the government; the 
other 15% opt for private insurance which often covers more. In France the entire population 
must pay compulsory government insurance. In Korea healthcare is provided to all citizens and 
residents by a mixed public-private system, much of the care is private with a few community 
hospitals. Insurance is delivered by the government through the levy of a tax to the entire 
population. In all three cases government spending comprises close to 75% of total HCE, per 
OECD data. In contrast the British National Health System has been largely criticized for having 
rundown hospitals, shortages of specialists, long waiting lists, and an undersupply of 
equipment, issues which many universal health care systems have avoided largely due to 
efficient funding (Light 2003). This may contribute to the relatively small magnitude of the 
British time trend and its relative insignificance compared to the other nations, more than 3 
times less significant than the second most insignificant time trend, Italy.  
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Table 1: Results of SURS on Log Life Expectancy for the G7+Korea Nations 
Country 
Variables 
Canadian 
Life 
Expectancy  
French Life 
Expectancy 
German Life 
Expectancy  
Italian Life 
Expectancy  
Japanese 
Life 
Expectancy  
Korean Life 
Expectancy  
British Life 
Expectancy  
American 
Life 
Expectancy  
Model Stats R2=0.9990 
Pval=0.0000 
R2=0.9973 
Pval=0.0000 
R2=0.9998 
Pval=0.0000 
R2=0.9951 
Pval=0.0000 
R2=0.9971 
Pval=0.0000 
R2=0.9993 
Pval=0.0000 
R2=0.9978 
Pval=0.0000 
R2=0.9989 
Pval=0.0000 
Constant -0.33154 
(0.535) 
-9.51575*** 
(0.000) 
-3.07080*** 
(0.000) 
1.37398 
(0.311) 
-1.16157 
(0.333) 
-6.95200*** 
(0.000) 
1.32609* 
(0.015) 
-8.35410*** 
(0.000) 
Year (1989-
2009) 
0.00160*** 
(0.000) 
0.00511*** 
(0.000) 
0.00532*** 
(0.000) 
0.00173** 
(0.007) 
0.00292*** 
(0.000) 
0.00559*** 
(0.000) 
0.00051* 
(0.026) 
0.00597*** 
(0.000) 
% Pop Aged 0-14 - 0.02870*** 
(0.000) 
0.04495*** 
(0.000) 
-0.01327*** 
(0.000) 
- - 0.01613** 
(0.001) 
0.02358*** 
(0.000) 
% Pop Aged 15-
64 
0.01913*** 
(0.000) 
0.03046*** 
(0.000) 
-0.06594*** 
(0.000) 
- - - 0.02327*** 
(0.000) 
- 
Total 
Expenditures on 
Healthcare %GDP 
-0.00788*** 
(0.000) 
-0.00325** 
(0.004) 
-0.00417*** 
(0.000) 
- -0.02150*** 
(0.000) 
0.00616*** 
(0.000) 
- - 
Pharmaceutical 
Expenditures on 
Healthcare %HCE 
0.00328*** 
(0.000) 
- 0.00491*** 
(0.000) 
-0.00148*** 
(0.000) 
- 0.00175*** 
(0.000) 
- -0.00326*** 
(0.000) 
# Physicians per 
1,000 Pop 
- 0.01216** 
(0.008) 
-0.01278*** 
(0.000) 
- -0.05083*** 
(0.000) 
- - -0.01354*** 
(0.000) 
# Hospital Beds 
per 1,000 Pop 
0.00921*** 
(0.000) 
0.03214*** 
(0.000) 
0.02315*** 
(0.000) 
- -0.00226*** 
(0.000) 
- - 0.03331*** 
(0.000) 
Alcohol 
Consumption, 
Liters per Pop 
Aged 15+ 
- -0.00624*** 
(0.000) 
0.00299*** 
(0.000) 
-0.00674*** 
(0.000) 
0.00811*** 
(0.000) 
0.00240** 
(0.001) 
0.00598*** 
(0.000) 
-0.16345** 
(0.002) 
Alcohol 
Consumption 
Squared 
- - - - - - - 0.00782* 
(0.013) 
Tobacco 
Consumption, % 
of Adults 
Smoking Daily 
0.00106*** 
(0.000) 
0.00340*** 
(0.000) 
- - -0.00156** 
(0.001) 
- - 0.00333*** 
(0.000) 
Vaccination Rates 
Against DTP 
- 0.00717*** 
(0.000) 
-0.00007*** 
(0.000) 
-0.00106*** 
(0.000) 
-0.00018*** 
(0.000) 
- 0.00110*** 
(0.000) 
- 
Vaccination Rates 
Against MMR 
0.00143*** 
(0.000) 
- - - - - 0.00049*** 
(0.000) 
-0.00140*** 
(0.000) 
Vaccination Rates 
Against Influenza 
65+ 
0.00034*** 
(0.000) 
0.00211*** 
(0.000) 
0.00014*** 
(0.000) 
-0.00065*** 
(0.000) 
0.00037*** 
(0.000) 
- 0.00029** 
(0.007) 
0.00064*** 
(0.000) 
Incidence of 
Tuberculosis per 
100,000 Pop 
- -0.00426*** 
(0.000) 
-0.00114*** 
(0.000) 
- -0.00091*** 
(0.000) 
- 0.00056*** 
(0.005) 
- 
 Unemployment 
Rate 
0.00106* 
(0.016) 
0.00159*** 
(0.000) 
-0.00311*** 
(0.000) 
-0.00405*** 
(0.000) 
0.00717*** 
(0.000) 
0.00051* 
(0.010) 
- -0.00291*** 
(0.000) 
Observations 17 
p-values in parentheses: * p<0.05, ** p<0.01, *** p<0.001 
 Population distribution variables in the sense of affecting life expectancy are difficult to 
interpret except that they have the potential to affect the tax base for any social spending 
Modeling Health Care Quality 
12 
 
programs. When you have a high percentage of population in the tails of the age distribution, 0-
14, and 65+, not only are these populations more likely to experience health issues which could 
influence LE but they also contribute little to the national accounts for social programs based 
on an income tax. The signs for the 0-14 coefficient are positive in France, Germany, Britain, 
and the US, then negative in Italy; all are statistically distinguishable from zero. For the 15-64 
coefficients, the signs are positive in Canada, France, and Britain; then negative in Germany; 
again all are statistically distinguishable from zero. The data do not conclusively point either 
way on this issue, likely as a result of the structural differences of health care delivery in the 
different countries. 
The more interesting and economically significant findings are found in the 
interpretation of the coefficients on HCE. Throughout developed world HCE is in a state of 
insignificance, in Italy, Britain, and the US, or significantly negative in France, Germany, and 
Japan. The only outlier here is Korea with a significantly positive HCE coefficient. This result 
adds credence to the theory set forth by Zweifel where countries can enter states of negative 
returns as a result of inefficiency in funding allocations. At the writing of this manuscript no 
studies have examined any causal relationship to explain this apparent divide. This healthcare 
delivery dichotomy warrants significant additional study and is potentially invaluable to future 
structural reforms.  
Pharmaceutical expenditure on healthcare is a measure of research and development 
into advanced drug therapies as well as a measure of the sophistication of healthcare delivery 
in a country. In many countries it is either statistically insignificant, as in France, Japan, and 
Britain, or significant but negative as in Italy and the United States. This would seem to indicate 
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inefficiencies in spending or just a labored return on investment for researching new drugs due 
to regulatory or fiscal environments. The only countries with significant positive coefficients 
were Canada, Germany, and Korea.  
Busse et al. in 2005 discussed new regulation of the pharmaceutical market in Germany. 
They cited spending caps for pharmaceutical expenditure per physicians' association and 
discussed changes in efficiency of fund allocation. Although many of these countries have 
experienced shifts in regulatory environment over the past 20 years, it appears that Germany is 
doing something right and further models should be examined to explain this relationship.  
The effect of the number of physicians in the market reflect to what degree the number 
of medical graduates have matched the increase or decrease in demand in the population. This 
interpretation lends itself nicely to determine generally whether a market is oversaturated or 
under saturated with respect to licensed physicians. Countries with extensively subsidized 
health care have been plagued by decreasing interest in the medical field due to declining 
returns to the extensive investment in education, both money and time. This likely contributes 
to the insignificance of the physician variable in Canada, Italy, Korea, and Britain. For example, 
Britain has chronically lacked specialists (Light 2003).  
The variable is positively significant in only France and negatively significant in Germany, 
Japan and the US. The positive correlation would support the training and licensure of more 
physicians to meet a growing need. The negative significance supports the notion that either 
doctors aren’t being licensed in specialties appropriately to suit the population demand or that 
the market itself is overly saturated and the country needs fewer doctors. This is likely to 
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change in the US very soon as the demand for physicians soars with nearly 32 million additional 
Americans to be insured under the new health care bill (Congressional Budget Office 2010). 
There is a similar interpretation for the coefficient on hospital beds. Italy, Korea, and 
Britain all have insignificant hospital bed variables. Only Japan has a significant negative 
coefficient. Canada, France, Germany, and the US all have a positive coefficient. This variable 
can capture significance in healthcare delivery as a result of infrastructure, specifically 
hospitals. For the positive coefficient nations, populations would live longer if their hospital 
infrastructure was expanded whereas Japan should look at finding more elastic methods of 
providing infrastructure to better approximate the ebb and flow of its demand function.   
Interestingly, where we see significant estimates for both, physicians and hospital beds, 
the sign is the same in two of the four cases. In Japan we see significant negative coefficients 
for both physician and hospital bed variables. In France we see significant positive coefficients 
for both physician and hospital bed variables whereas in Germany and the US we have one 
positive and one negative coefficient. This only serves to reinforce the idea that there is some 
systematic difference in efficiency between healthcare delivery mechanisms in these countries. 
Alcohol consumption is significant in seven of eight regressions. It is significantly positive 
in Germany, Japan, Korea, and Britain whereas it is negative in France, Italy, and the US. This 
difference is likely related to the relative attitudes and behaviors of individuals in the various 
countries. In countries where binge drinking is more prevalent, this variable should be negative 
and large in magnitude; whereas countries with generally responsible drinking populations 
have the potential to experience a positive coefficient. There have been studies which show 
significant decreases in mortality by all causes in individuals who partake in moderate drinking 
Modeling Health Care Quality 
15 
 
(Lee 2009). In terms of magnitude, these negative coefficients are quite significant, the US 
coefficient is the largest magnitude coefficient in the model. The alcohol squared term for the 
US exhibits the expected sign, namely that this negative relationship between life expectancy 
and alcohol consumption is diminishing as the number of liters consumed increases. From this 
information it is reasonable to infer that there is some difference in societal behavior with 
respect to alcohol consumption amongst these countries.     
Tobacco consumption is significantly negative in only Japan, positive in Canada, France, 
and the US and insignificant in all other cases. The sign is for these three nations is completely 
unexpected and a mysterious result. However, rates of tobacco consumption in the 
industrialized world have decreased rapidly since the 1960s, perhaps a larger time series would 
provide more revealing coefficients in these countries. Perhaps tobacco consumption is also 
collinear with some unobserved factor.  
The vaccination rate for diphtheria is insignificant for three of eight models, Canada, 
Korea, and the US. It maintains the expected result, a positive coefficient where ceteris paribus 
getting vaccinated against diphtheria increases life expectancy in two of the remaining models, 
France, and Britain. In Germany, Italy, and Japan it is negative in sign, however the German and 
Japanese coefficients are relatively insignificant in magnitude. One possible explanation for this 
phenomenon is that the incidence rate of diphtheria is so small across these countries that the 
negative side effects of the vaccine itself are influencing overall life expectancy more than the 
potential averted disease instances.  
The vaccination rate for measles is insignificant in five of eight models, all except 
Canada, Britain, and the US. In Canada and Britain it carries the expected positive sign. In the US 
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it carries a negative sign. Measles could be another example where the rate of incidence has 
become so asymptotically close to zero that these coefficients need more years of data when 
vaccination rates were lower to provide more telling results. 
Vaccination against influenza for the elderly has long been encouraged to prevent 
potentially debilitating bouts of pneumonia. In this log LE model we see that in Korea it is 
insignificant. In six other cases it is significantly positive, Canada, France, Germany, Japan, 
Britain, and the US. It is only negative in Italy. In Italy it may be the case that the incidence of 
influenza is similar to that of diphtheria, quite low and these vaccinations may not be 
necessary. Despite the fact that influenza is a virus that experiences a high frequency mutation 
rate making it difficult to combat these data clearly show an appreciable benefit from 
immunization in the elderly.  
Incidence of tuberculosis is a statistically significant negative variable in France, 
Germany, and Japan. It follows intuition in sign in all three cases, higher rates of this contagious 
and long lived disease decrease life expectancy. France, Germany, and Japan are all countries 
which experience significant positive immigrant populations. This is an interesting correlation 
because in general immigrant populations cause higher rates of tuberculosis due to tighter 
quarters and less access to health care due to financial limitations. However, Britain also has 
significant immigration and has a significant positive relation which is not easily explained. It 
would be an interesting side study to attempt to characterize any structural relationship 
between tuberculosis and immigration. 
The final variable in the first model is the unemployment rate for each country over the 
20 year period. Unemployment is significant in all but one case, Britain. It is significantly 
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positive in Canada, France, Japan, and Korea. In Germany, Italy, and the US it follows the 
intuition of a negative sign. It is reasonable to say in times of elevated unemployment 
disposable income decreases. This shift away from exotic to practical expenditures is one that 
may result in increased LE, however at some point it would obviously become a significant 
enough hardship to reduce LE. The logic follows that in order for unemployment, a generally 
cyclical macro factor to affect someone’s ability to access healthcare in a life expectancy 
impacting situation; it must have been at a high rate for a substantial duration, something that 
is generally rare. It would be interesting if it were possible to perform a similar analysis over a 
greater time period. 
Examining HCE Regressions: 
Next this study examines the results of applying Zweifel’s and Breyer’s methodologies for 
detangling the driving forces behind rising HCE. In Table 2 are the results of applying Zweifel’s 
SISYPH variable construction and regressing that upon HCE with a time trend. We see clear 
evidence for a significant positive SISYPH variable in Canada, Korea, and Britain. The German 
model shows a negative SISYPH variable and the rest of the models do not show significance.  
Table 2: Testing Zweifel’s SISYPH Regressor on the G7+Korea 
Country 
Variables 
Canadian HCE French HCE German HCE Italian HCE Japanese HCE Korean HCE British HCE American HCE 
Model Stats R2=0.7374 
Pval=0.000 
R2=0.8269 
Pval=0.000 
R2=0.8373 
Pval=0.000 
R2=0.6469 
Pval=0.000 
R2=0.9453 
Pval=0.000 
R2=0.9562 
Pval=0.000 
R2=0.8979 
Pval=0.000 
R2=0.9295 
Pval=0.000 
Constant 769.51*** 
(0.000) 
-241.21 
(0.119) 
-563.72*** 
(0.000) 
105.42 
(0.632) 
-334.90 
(0.051) 
257.48*** 
(0.000) 
27.076 
(0.607) 
-447.02*** 
(0.000) 
Year -0.39441*** 
(0.000) 
0.12529 
(0.117) 
0.29068*** 
(0.000) 
-0.05149 
(0.647) 
0.17168* 
(0.049) 
-0.12872*** 
(0.000) 
-0.01643 
(0.548) 
0.23045*** 
(0.000) 
SISYPH 0.12291*** 
(0.000) 
0.00313 
(0.849) 
-0.02443*** 
(0.000) 
0.01667 
(0.230) 
-0.00274 
(0.665) 
0.03888*** 
(0.000) 
0.04727*** 
(0.000) 
0.00096 
(0.967) 
Observations 17 
p-values in parentheses: * p<0.05, ** p<0.01, *** p<0.001 
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In his 2002 paper, Zweifel suggests that over the course of the early 1990’s policy 
implementations had led to a suppression of the SISYPHUS Syndrome. However, these results 
seem to suggest that there are still SISYPH operative nations well into the 2000’s. 
Table 3: Testing Further HCE Models on the G7+Korea 
Country 
Variables 
Ln Canadian 
HCE 
Ln French 
HCE 
Ln German 
HCE 
Ln Italian 
HCE 
Ln Japanese 
HCE 
Ln Korean 
HCE 
Ln British 
HCE 
Ln American 
HCE 
Model Stats R2=0.9152 
Pval=0.000 
R2=0.9009 
Pval=0.000 
R2=0.9381 
Pval=0.000 
R2=0.8592 
Pval=0.000 
R2=0.9886 
Pval=0.000 
R2=0.9568 
Pval=0.000 
R2=0.9589 
Pval=0.000 
R2=0.9839 
Pval=0.000 
Constant -97.798** 
(0.001) 
-26.918 
(0.132) 
-24.509** 
(0.008) 
137.09* 
(0.025) 
151.63*** 
(0.000) 
207.80* 
(0.036) 
-78.703*** 
(0.000) 
-20.258*** 
(0.000) 
Year 0.07111*** 
(0.000) 
0.03171 
(0.078) 
0.02810*** 
(0.000) 
-0.07390 
(0.26) 
-0.06482** 
(0.003) 
-0.13351* 
(0.025) 
-0.01012** 
(0.009) 
0.02157*** 
(0.000) 
Ln Life 
Expectancy 
-9.8456*** 
(0.000) 
-3.8511 
(0.343) 
-2.4871* 
(0.015) 
6.2102 
(0.088) 
-7.6599** 
(0.001) 
15.769* 
(0.018) 
25.263*** 
(0.000) 
-5.7296*** 
(0.000) 
Ln 
Remaining 
LE at 65 
3.8733*** 
(0.000) 
0.29702 
(0.773) 
-0.05063 
(0.910) 
-0.15139 
(0.866) 
2.09198*** 
(0.000) 
-4.6459* 
(0.021) 
-4.4916*** 
(0.000) 
0.74286* 
(0.013) 
% Pop 15-64 -0.07199* 
(0.033) 
-0.25289* 
(0.036) 
-0.23518*** 
(0.000) 
-0.23159*** 
(0.000) 
0.06170*** 
(0.000) 
-0.03384 
(0.642) 
0.04125* 
(0.018) 
0.05894*** 
(0.000) 
% Pop 65+ -0.44079*** 
(0.000) 
-0.10926 
(0.295) 
-0.14548*** 
(0.000) 
0.08842 
(0.208) 
0.18918*** 
(0.000) 
0.40951** 
(0.008) 
0.06457 
(0.377) 
-0.11314* 
(0.03) 
Observations 17 
p-values in parentheses: * p<0.05, ** p<0.01, *** p<0.001 
In Table 3 are the results of a SUR study following the construction detailed by Breyer et 
al in their 2011 paper. Although Breyer uses a fixed effects intrinsic estimator for his individual 
observations; I have attempted a similar construction using SUR in an effort to characterize the 
differences in HCE experienced by different countries.  
In the Log HCE estimator we see significant time trends in every country except France, 
and Italy. Canada, Germany, and the US experience positive time trend coefficients whereas 
Japan, Korea, and Britain show a significant negative time trend. This is further evidence for a 
structural difference in policy or mechanism of delivery of healthcare between the nations and 
possibly even more generally, the East and West.  
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Log LE is significant in six cases. In Korea and Britain it is significantly positive and in 
Canada, Germany, Japan, and the US it experiences the opposite sign.  It appears that in Korea 
and Britain longer life for the entire population drives HCE up whereas in Canada, Germany, 
Japan, and the US, longer life for the entire population drives HCE down.  
 Log RLE is significant in Canada, Japan, Korea, Britain and the US. In Canada, Japan, and 
the US it is significantly positive whereas in the Korea and Britain it is negative. The effects of 
elderly living longer is not consistent across countries and likely differs as the result of societal 
attitudes towards death dictating treatment at older age, limits of healthcare systems, or other 
unobserved factors. Breyer et al describe a negative relation with RLE and explain that 
physicians may treat those with what have appeared to be full lives less aggressively than 
younger patients with similar ailments or when resources are limited (Breyer 2011). If we are to 
attempt to apply this logic to the US it is possible that either doctors do not practice this ethical 
caveat or patients dictate more of their treatment in the US than in other countries. 
Interestingly it holds the opposite sign as Log LE in every case where both are statistically 
significant, Canada, Japan, Korea, Britain, and the US. This relationship deserves greater 
attention.   
 The two remaining variables describe the age composition of a countries population, 15-
64 or 65+ where 0-14 is the omitted category. Of the five cases where pop65+ is significant, 
three are negative indicating that ceteris paribus more elderly population decreases HCE in 
Canada, Germany, and the US. It is not crystal clear whether or not ageing population alone 
drives HCE in the other countries and in future studies hopefully the data will be more 
illuminating.  Breyer finds statistically revealing positive coefficients for his age composition 
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variables in his Germany specific fixed effects study, however; in this case we find negative 
significance in the middle aged and elderly segments.  
Conclusions and Areas for Future Research 
In this study I have essentially answered three main questions. First, how does life 
expectancy as a proxy for healthcare quality differ throughout the world? My SUR model has 
provided many factor variables that vary across country and characterize healthcare programs 
worldwide. Secondly, has the SISYPHUS Syndrome disappeared as Zweifel suggested in 2002? 
No, I have demonstrated through SURS that over the time period 1990-2009 there are clear 
statistically significant SISYPH variables in at least Canada, Germany, Korea, and Britain. Lastly, 
can we confirm Breyer’s model of HCE in Germany and can it be useful in other countries? Yes 
to a reasonable extent the methodologies were replicated in a SURS rather than fixed effects 
technique in an effort to simultaneously test and examine different variables in different 
countries. I was unable to confirm the results of Breyer in his 2011 examination of the sickness 
fund members. I was able to offer primitive characterizations of the other G7 countries and 
Korea and how their HCE move with respect to the same factor variables. Another area of 
future study would be to further analyze any causal relationship between HCE and life 
expectancy using instrument variables for HCE. 
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